Targeting cardiovascular risk in renal transplantation

Transplant Proc. 2001 Feb-Mar;33(1-2):1117-8. doi: 10.1016/s0041-1345(00)02454-4.

Authors

B A Kiberd¹, K A West

Affiliation

¹ Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

PMID: 11267217
DOI: 10.1016/s0041-1345(00)02454-4

No abstract available

MeSH terms

Cardiovascular Diseases / economics
Cardiovascular Diseases / mortality
Cardiovascular Diseases / prevention & control*
Cost of Illness
Cyclosporine / therapeutic use
Graft Rejection / prevention & control
Graft Survival
Humans
Immunosuppressive Agents / therapeutic use
Kidney Transplantation / economics
Kidney Transplantation / mortality*
Models, Biological*
Risk Factors

Substances

Immunosuppressive Agents
Cyclosporine